Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2001 June;49(3) > Minerva Cardioangiologica 2001 June;49(3):189-96



To subscribe
Submit an article
Recommend to your librarian





Minerva Cardioangiologica 2001 June;49(3):189-96


language: English, Italian

Therapeutic effects of Vascupump© treatment patients with Fontaine Stage II B arteriopathy

Allegra C., Bartolo M. Jr., Martocchia R.


Intermittent claudication is the primary symptom of chronic obstructive arteriopathies of the lower extremities. Increased walking distance is the aim of all physical or pharmacological treatment of such patients. The study reported aims to assess the increase in distal arterial blood flow in arteriopathic patients achieved by physical treatment using a cuff, generally positioned on the upper third of the thigh to produce pulsed compressions. By tightening for a few milliseconds slightly behind the natural cardiac systole, the cuff reinforces the systolic thrust to increase distal perfusion without making any additional demand, on the cardiac pump. The cuff used is produced by Vascupump© vp-El. The trial was conducted on 36 patients with intermittent claudication divided into 3 groups. Group A included 12 patients given Vascupump© treatment only (20¥45 minute sessions); Group B included 12 patients given combined treatment with the Vascupump© and endovenous Pentoxillin (3 fl/per diem for 20 days); Group C included 12 patients given Pentoxyfillin alone (3 n per diem for 20 days). Each patient was examined at the start (D0) and end (D20) of treatment as follows: Treadmill tests at 0 and 12% gradients at a speed of 3 km/h. Doppler arterial tensiometry with calculation of the Winsor Index; photoplethysmography.
Group A revealed an increase in relative and absolute walking distance of 230% and 224% respectively on the flat and 357% and 343% respectively uphill. Doppler tensiometry revealed a 40.7% improvement in Group A compared to 29% in Group B and 13.6% in Group C. By contrast the improvement in the plethysmographic reading was higher in Group B (+ 119%) than in Group A (+67.3%). These results suggest that the Vascupump© gives better than expected results on Fontaine Stage B arteriopathies.

top of page